Which medications decrease the risk of prostate cancer?
Metadata[+] Show full item record
The 5-alpha reductase inhibitors (5-ARI)—finasteride and dutasteride—decrease the risk of prostate cancer by approximately 25%; however, the effect on overall mortality is unknown. (SOR A, based on meta-analysis.)
Evidence Based Practice 13(4): 08.